Drug Manufacturers - Specialty & Generic · Healthcare
CEO
2022-02-14–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Ascend Wellness Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get AAWH alertsFrank Perullo is recorded as CEO at Ascend Wellness Holdings, Inc. (AAWH). Ascend Wellness Holdings, Inc. reported in an 8-K filed September 28, 2022 that Frank Perullo was appointed Interim Co-CEO, effective September 27, 2022. The proxy statement of Ascend Wellness Holdings, Inc. reports total compensation of $3,039,786 for Frank Perullo in fiscal 2022, including a base salary of $750,000. Disclosed compensation is on record for 3 fiscal years. Ascend Wellness Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Ascend Wellness Holdings, Inc. includes Samuel Brill (CEO and Board Member), Abner Kurtin (Chairman and Board Member), Mark Cassebaum (CFO) and 7 others.
“On September 28, 2022, Ascend Wellness Holdings, Inc. (the "Company") announced that President & Co-founder Frank Perullo and Chief Financial Officer Daniel Neville had been appointed Interim Co-CEOs, effective as of September 27, 2022.”
2022-02-14–present
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
2022-02-14–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Ascend Wellness Holdings, Inc. (AAWH) | President and Interim Co-Chief Executive Officer | $750,000 | $3,039,786 |
| 2021 | Ascend Wellness Holdings, Inc. (AAWH) | President and Interim Co-Chief Executive Officer | $667,500 | $10,025,673 |
| 2020 | Ascend Wellness Holdings, Inc. (AAWH) | President and Interim Co-Chief Executive Officer | $384,808 | $880,587 |